Beckley Psytech receives FDA Investigational New Drug (IND) approval for Phase IIb study of BPL-003,

[VibeSurfer]

Beckley Psytech receives FDA Investigational New Drug (IND) approval for Phase IIb study of BPL-003, a novel synthetic formulation of 5-MeO-DMT (Mebufotenin)

Beckley Psytech Ltd, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric disorders by transforming psychedelics i

www.businesswire.com

Very cool! I would love to see the average person have access to 5-meo-dmt for depression.